Market Overview

UPDATE: ISI Group Initiates Allscripts Healthcare Solutions with Market Weight, $11 PT on Product Development Overhang

Share:
Related MDRX
Benzinga's Top Downgrades
New Survey Gives J.P. Morgan Confidence To Go Overweight Athenahealth, Allscripts & Advisory Board

ISI Group initiated its coverage on Allscripts Healthcare Solutions (NASDAQ: MDRX) with a rating of Market Weight and a price target of $11.

ISI Group noted, "Our thesis for MDRX is based on continued issues related to product development efforts and the overhang that this creates on bookings growth, the potential for renewed cross-sell opportunities following the product revamp, and the trade-off between cost synergies and increased R&D spending limiting margin expansion opportunities. However, with the recent sell-off in the stock, we think that the appropriate risk level is assumed in valuation and MDRX continues to have one of the largest installed bases in the market."

Allscripts Healthcare Solutions closed at $10.21 on Wednesday.

Latest Ratings for MDRX

DateFirmActionFromTo
Jan 2016RBC CapitalUpgradesSector PerformOutperform
Jan 2016Raymond JamesDowngradesOutperformMarket Perform
Nov 2015JP MorganAssumesOverweight

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (MDRX)

Get Benzinga's Newsletters